Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Yangnong’s dicamba plant starts trial production

Chinese agrochemical Jiangsu Yangnong Chemical has started trial production on a new production line for three agrochemical active ingredients, including a 5,000 tonnes/year facility for the herbicide, dicamba, report the Chinese stock market analyst, China International Capital. The plant, based in the city of Nantong, will go into full operation in January. With this new facility, Yangnong’s total dicamaba capacity is set to become some 6,500 tonnes/year, reportedly over 30% of the global manufacturing capacity for the herbicide. The company’s dicamba production is estimated to be worth some Yuan 800 million ($130.7 million at the current rate) in annual revenue. Work will begin on the second phase of the Nantong production plant in 2015, and is expected to be completed by 2016. Yangnong, a subsidiary of Chinese state-owned chemical giant Sinochem, recorded a 5.1% fall in agrochemical sales to 2,088.7 million ($341.3 million) in the first three quarters of 2014.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG021624

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel